SGLT2 Inhibitor Safety Signals in FAERS Ketoacidosis and other adverse events across 154,476 spontaneous reports. Diabzen, [S. l.], v. 4, n. 16, p. 32–33, 2026. Disponível em: https://thediabzen.com/index.php/d/article/view/59. Acesso em: 29 jul. 2026.